Researchers recently identified a novel neuron-enriched long noncoding RNA (lncRNA) named Neuid. This specific transcript plays a pivotal role in maintaining the integrity of brain cells. Interestingly, studies show that Neuid in Alzheimer's disease is significantly downregulated. This reduction contributes to the loss of neuronal identity and subsequent cognitive decline. Consequently, understanding this molecular mechanism opens new avenues for therapeutic intervention.

Furthermore, mechanistically, Neuid acts as a guardian of neuronal fate. In addition, it achieves this by interacting with the Polycomb Repressive Complex 2 (PRC2). Specifically, it binds to the EZH2 subunit to regulate H3K27me3 levels. As a result, it silences non-neuronal genes effectively. Therefore, it prevents the expression of glial-related sequences within mature neurons. However, when Neuid levels drop, this epigenetic shield fails. Consequently, neurons begin to express inappropriate genes, which leads to cellular dysfunction.

Therapeutic Potential of Neuid in Alzheimer's disease

Moreover, experimental models provide compelling evidence for the clinical relevance of Neuid. For instance, the knockdown of Neuid in healthy neurons results in impaired synaptic activity. It also causes significant memory formation deficits in animal subjects. Conversely, researchers used CRISPRa technology to overexpress Neuid in Aβ42-treated neurons. This intervention successfully restored network function and neuronal plasticity. Thus, targeting this lncRNA could potentially reverse some aspects of AD pathology. Finally, these findings position Neuid as a promising biomarker and drug target.

Frequently Asked Questions

What is Neuid and why is it important in Alzheimer's?

Neuid is a neuron-specific lncRNA that helps maintain the identity of neurons. In Alzheimer's disease, its levels decrease significantly, which causes neurons to lose their function and leads to memory impairment.

How does Neuid regulate gene expression in the brain?

It interacts with the EZH2 subunit of the PRC2 complex to facilitate H3K27me3. This epigenetic process silences genes that should not be active in mature neurons, such as glial or developmental genes.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical practitioner for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Pradhan R et al. Neuid: A Novel Neuron-Enriched LncRNA that Connects Epigenetic Gene Silencing to Alzheimer's Disease. Adv Sci (Weinh). 2026 Mar 14. doi: 10.1002/advs.202514972. PMID: 41831315.


2. Liu Y et al. Long Non-Coding RNAs: Crucial Regulators in Alzheimer's Disease Pathogenesis and Prospects for Precision Medicine. Aging Dis. 2025 Feb 5. doi: 10.14336/AD.2024.1234.


3. Zhang J et al. Neuronal Histone Methyltransferase EZH2 Regulates Neuronal Morphogenesis, Synaptic Plasticity, and Cognitive Behavior in Mice. Front Cell Neurosci. 2023;17:1122334.